Open AccessOptimization of payment for therapy with genetically engineered biological drugs and selective immunosuppressants at the expense of compulsory medical insurance fund in a day hospital at the regional level
Author(s) -
М. В. Сура,
T Boyarskaya,
E.V. Derkach
Publication year - 2021
Publication title -
medicinskie tehnologii. ocenka i vybor
Language(s) - English
Resource type - Journals
eISSN - 2712-7877
pISSN - 2219-0678
DOI - 10.17116/medtech20214303153
Subject(s) - payment , business , actuarial science , medical insurance , genetically engineered , health insurance , medicine , pharmacology , finance , economics , genetics , economic growth , gene , health care , biology